ALK and non-small cell lung carcinoma: Depending on the histological subtype, the genetic profile of the tumor, and the stage of disease, NSCLC treatment includes surgery, radiation therapy, chemotherapy, as well as targeted therapies (Kirsten rat sarcoma virus (KRAS), epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK) inhibitors).